GO:0051018 protein kinase A binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051018 (protein kinase A binding) is a molecular function defined as binding to a protein kinase A (PKA).
• PKA is a cyclic AMP-dependent kinase whose catalytic and regulatory subunits interact with a wide range of anchoring proteins and substrates.
• Protein kinase A binding is mediated by conserved docking motifs and structural elements on PKA subunits and their partners.
• Isoform-specific sequestration of PKA fine-tunes intracellular signaling, as shown during heat stress.
• PKA binding and anchoring are conserved across evolution, including in pathogens such as Leishmania.
• Dysregulated PKA binding contributes to cancer, metabolic disorders, and infectious disease, making it a key research and therapeutic target.
Description
Protein kinase A (PKA) is a cyclic AMP-dependent serine/threonine kinase that controls diverse cellular processes, including metabolism, gene expression, proliferation, and differentiation. The molecular function GO:0051018, protein kinase A binding, describes the selective physical interaction of a protein with PKA. This binding event is central to PKA signaling because it determines where, when, and how PKA phosphorylates its substrates. Researchers study protein kinase A binding to understand signal transduction specificity, subcellular compartmentalization, and disease mechanisms. The interaction is mediated by conserved structural features on PKA and its binding partners, and it can be modulated by isoform composition and cellular context. Because PKA is a major therapeutic target, mapping its binding interfaces and regulatory interactions is essential for drug discovery and for interpreting disease-associated mutations.
protein kinase A binding At A Glance
| GO ID | GO:0051018 |
|---|---|
| GO term | protein kinase A binding |
| Ontology | molecular_function |
| Synonym | PKA binding; protein kinase A anchoring activity |
| Major function | Binding to a protein kinase A (PKA) enzyme |
| Definition source | QuickGO |
| Related processes | cAMP signaling, phosphorylation, signal transduction |
| Evidence | Experimental evidence codes in QuickGO |
What Is GO:0051018?
GO:0051018 (protein kinase A binding) is a molecular function term that describes the binding of a protein or other molecule to a protein kinase A (PKA). It encompasses interactions with PKA catalytic subunits, regulatory subunits, or holoenzymes, and includes anchoring events that localize PKA to specific subcellular compartments. The term is supported by experimental evidence and is used to annotate gene products that physically associate with PKA.
Why Is protein kinase A binding Important in Cell Biology?
Protein kinase A binding is important because it governs the specificity and spatial organization of one of the most pervasive signaling pathways in eukaryotes. By anchoring PKA to specific subcellular locations, binding proteins ensure that phosphorylation events occur at the right place and time, which is critical for normal physiology and for preventing disease. Disruption of PKA binding interactions has been linked to cancer, metabolic disorders, and pathogen virulence, making this function a focal point for both basic research and therapeutic development.
• Controls subcellular localization of PKA, which is essential for signal specificity.
• Regulates phosphorylation of key substrates involved in metabolism, transcription, and cell cycle.
• Isoform-specific binding fine-tunes signaling during stress responses such as heat shock.
• Conserved in pathogens like Leishmania, where PKA binding is required for morphogenesis.
• Dysregulation contributes to cancer through altered PKA signaling and substrate targeting.
• Mutations in PKA subunits affect inhibitor binding and can lead to disease.
• Provides targets for pharmacological modulation of cAMP pathways.
• Enables experimental dissection of signaling networks using binding assays.
• Influences RNA-binding protein activity and gene expression, as shown for COX-2 regulation.
• Serves as a model for understanding kinase anchoring and scaffold proteins.
Molecular Mechanism of protein kinase A binding
PKA holoenzyme architecture and subunit interfaces
In simple terms: PKA is made of parts that can bind to other proteins.
Protein kinase A is a tetrameric holoenzyme composed of two catalytic subunits and two regulatory subunits. The catalytic subunits contain a conserved kinase domain with a glycine-rich loop that is important for ATP binding and inhibitor interactions. The regulatory subunits have pseudosubstrate sequences that inhibit catalytic activity until cAMP binds. Binding to PKA can occur through interactions with either subunit type, and the structural details of these interfaces are critical for understanding specificity.
Anchoring proteins and subcellular targeting
In simple terms: Anchor proteins hold PKA in specific places inside the cell.
A major mechanism of protein kinase A binding involves A-kinase anchoring proteins (AKAPs), which bind to the regulatory subunits of PKA and tether the enzyme to specific subcellular locations. This anchoring ensures that PKA phosphorylates nearby substrates efficiently and selectively. The binding is mediated by a conserved amphipathic helix on AKAPs that docks into a hydrophobic groove on the PKA regulatory subunit. Isoform-specific sequestration of PKA further refines signaling during conditions like heat stress.
Conformational dynamics and substrate recognition
In simple terms: PKA changes shape when it binds partners, which affects what it can do.
Binding to PKA can stabilize or alter the conformation of both partners, influencing catalytic activity and substrate selection. For example, phosphorylation of Raf kinase inhibitory protein by PKA involves a conformationally high-energy state, highlighting how dynamic interactions control function. The glycine-rich loop of the catalytic subunit contributes to nucleotide and inhibitor binding, and mutations in this motif alter binding properties. These structural features are essential for understanding how PKA binding translates into specific biological outcomes.
Isoform-specific interactions and regulation
In simple terms: Different versions of PKA bind different partners, allowing fine control.
PKA catalytic subunit isoforms, such as PRKACA, exhibit distinct expression patterns and binding preferences. Isoform-specific sequestration of PKA can fine-tune intracellular signaling, as demonstrated during heat stress where specific isoforms are held in distinct complexes. In pathogens like Leishmania, a divergent PKA regulatory subunit is essential for morphogenesis, showing evolutionary diversification of binding mechanisms. These isoform differences are important for designing selective modulators and for interpreting disease mutations.
Regulation by cAMP and post-translational modifications
In simple terms: cAMP and chemical tags control how PKA binds and works.
The binding of cAMP to PKA regulatory subunits releases the catalytic subunits, allowing them to phosphorylate substrates. This activation is a prerequisite for many protein kinase A binding events that target the active catalytic subunit to specific substrates. Post-translational modifications, such as myristylation, can influence PKA membrane interactions and binding properties. Additionally, PKA can regulate RNA-binding proteins like HuR and TTP, affecting gene expression at the post-transcriptional level.
Key Genes Involved in GO:0051018 protein kinase A binding
The following genes and proteins are central to protein kinase A binding, either as PKA subunits or as binding partners that mediate anchoring and substrate targeting.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKACA | Catalytic subunit of PKA; phosphorylates substrates | Isoform-specific functions and disease mutations |
| PRKACB | Catalytic subunit isoform of PKA | Isoform-specific signaling and binding |
| PRKACG | Catalytic subunit isoform of PKA | Testis-specific functions and binding |
| PRKAR1A | Type I regulatory subunit; binds cAMP and anchors PKA | Mutations cause Carney complex; anchoring defects |
| PRKAR1B | Type I regulatory subunit isoform | Neuronal signaling and binding specificity |
| PRKAR2A | Type II regulatory subunit; binds AKAPs | Anchoring and subcellular targeting |
| PRKAR2B | Type II regulatory subunit isoform | Metabolic regulation and binding |
| AKAP1 | Mitochondrial AKAP; binds PKA regulatory subunits | Mitochondrial signaling and apoptosis |
| AKAP5 | Postsynaptic AKAP; anchors PKA in neurons | Synaptic plasticity and neuronal signaling |
| AKAP6 | Nuclear envelope AKAP; binds PKA | Nuclear signaling and gene regulation |
| AKAP9 | Centrosomal AKAP; binds PKA | Cell cycle and centrosome function |
| AKAP12 | Cytoskeletal AKAP; binds PKA | Cell migration and cancer |
| AKAP13 | Rho-GEF and AKAP; binds PKA | Stress fiber formation and signaling |
| RKIP | Raf kinase inhibitory protein; binds and is phosphorylated by PKA | Conformational dynamics and cancer |
| HuR | RNA-binding protein regulated by PKA | mRNA stability and COX-2 expression |
| TTP | RNA-binding protein regulated by PKA | mRNA decay and inflammation |
| Leishmania PKAR | Divergent PKA regulatory subunit | Pathogen morphogenesis and drug targets |
How Is protein kinase A binding Regulated?
Protein kinase A binding is regulated at multiple levels. cAMP binding to regulatory subunits triggers conformational changes that release active catalytic subunits, which then interact with substrates and anchoring proteins. Isoform-specific sequestration of PKA can dynamically modulate signaling during stress, as shown for heat stress responses. Post-translational modifications such as myristylation affect membrane association and binding properties. Additionally, PKA activity can regulate RNA-binding proteins, creating feedback loops that influence gene expression. In pathogens, divergent regulatory subunits control PKA binding and are essential for morphogenesis.
protein kinase A binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKAR1A | Carney complex; endocrine tumors | Knockout or point-mutation cell lines |
| PRKACA | Cushing's syndrome; adrenal hyperplasia | Knock-in of disease mutations |
| RKIP | Cancer metastasis; Raf signaling | Overexpression and phosphorylation assays |
| Leishmania PKAR | Parasite morphogenesis and virulence | Knockout in Leishmania |
| AKAP9 | Cancer; centrosome amplification | Knockout and imaging |
Cancer and PKA binding dysregulation
Altered protein kinase A binding and anchoring can contribute to cancer by mislocalizing PKA and disrupting phosphorylation of substrates that control proliferation and survival. For example, PKA regulates cyclooxygenase-2 expression through RNA-binding proteins HuR and TTP, linking PKA signaling to inflammation and tumor progression. Mutations in PKA subunits can affect inhibitor binding and catalytic activity, potentially driving oncogenic signaling. Targeting PKA binding interfaces is therefore an active area of cancer research.
Genetic disorders and PKA subunit mutations
Mutations in genes encoding PKA subunits, such as PRKAR1A, cause Carney complex and other disorders characterized by endocrine tumors and pigmented lesions. These mutations often disrupt cAMP binding or anchoring interactions, leading to constitutive PKA activity. Understanding how these mutations affect protein kinase A binding is critical for diagnosis and for developing targeted therapies.
Infectious disease and pathogen PKA
In pathogens like Leishmania, a divergent PKA regulatory subunit is essential for morphogenesis and virulence. This highlights how protein kinase A binding mechanisms can be species-specific and represent potential drug targets. Studying these interactions may lead to new treatments for parasitic infections.
Metabolic and stress-related disorders
Isoform-specific sequestration of PKA fine-tunes signaling during heat stress, and dysregulation of this process may contribute to stress-related pathologies. PKA binding also influences metabolic pathways through phosphorylation of key enzymes, and disruptions can lead to metabolic disorders. Research into these mechanisms may reveal new therapeutic opportunities.
From protein kinase A binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PKA binding affect substrate phosphorylation? | Knockout of anchoring protein |
| How do disease mutations alter PKA binding affinity? | Point-mutation knock-in |
| Where does PKA bind in live cells? | Tagged knock-in (e.g., GFP) |
| Does overexpression of PKA subunit alter signaling? | Overexpression cell line |
| Which genes are regulated by PKA binding? | CRISPR library screening |
| What is the interactome of PKA? | Bioinformatics and proteomics |
How to Study the protein kinase A binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pull-down assay | Physical interaction with PKA | Validate binding partners |
| SPR/ITC | Binding affinity and kinetics | Quantify PKA-peptide interactions |
| Kinase assay | Phosphorylation activity | Measure PKA catalytic function |
| FRET biosensor | Real-time PKA activity and localization | Live-cell imaging |
| RNA-seq | Gene expression changes | Identify PKA-regulated transcripts |
| Proteomics | Protein interactions and modifications | Map PKA interactome |
| CRISPR screen | Genes required for PKA binding | Functional genomics |
Binding assays (pull-down, SPR, ITC)
Direct measurement of protein kinase A binding can be performed using pull-down assays, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC). These methods quantify affinity and kinetics of interactions between PKA subunits and binding partners. They are essential for validating candidate binding proteins and for assessing the impact of mutations.
Phosphorylation and signaling assays
PKA activity and substrate phosphorylation can be measured using in vitro kinase assays, phospho-specific antibodies, and mass spectrometry. These approaches reveal how binding events translate into functional outcomes. For example, phosphorylation of RKIP by PKA can be monitored to study conformational dynamics.
Imaging and localization studies
Fluorescence microscopy, including FRET-based biosensors, can visualize PKA binding and localization in live cells. Tagged PKA subunits or anchoring proteins allow tracking of dynamic interactions. These methods are critical for understanding spatial regulation of PKA signaling.
Genomic and proteomic approaches
RNA-seq, proteomics, and CRISPR screening can identify genes and pathways regulated by PKA binding. For instance, PKA regulation of RNA-binding proteins affects mRNA stability, which can be studied by RNA-seq. Large-scale interaction studies can map the PKA interactome.
How CRISPR Can Be Used to Study GO:0051018 protein kinase A binding
Knockout
CRISPR knockout of genes encoding PKA subunits or anchoring proteins can abolish specific binding interactions, allowing researchers to study loss-of-function phenotypes. For example, knocking out PRKAR1A can disrupt PKA anchoring and alter downstream signaling. Knockout models are essential for determining causality in PKA binding pathways.
Point Mutation
Point mutations can be introduced into PKA subunits or binding partners to mimic disease-associated variants or to disrupt specific binding interfaces. For instance, mutations in the glycine-rich loop of PKA affect inhibitor binding and can be modeled using CRISPR. These models help dissect the structural basis of protein kinase A binding.
Knock-in
Knock-in of tagged PKA subunits (e.g., GFP or HA) enables visualization and purification of PKA complexes in native contexts. Knock-in of disease mutations can recapitulate human phenotypes in cell models. These approaches are valuable for studying dynamic binding events.
Overexpression
Overexpression of PKA subunits or binding partners can amplify signaling and reveal gain-of-function effects. For example, overexpressing PRKACA can enhance phosphorylation of substrates and alter cellular behavior. Overexpression models are useful for screening inhibitors and studying pathway activation.
How EDITGENE Supports protein kinase A binding Research
Researchers studying protein kinase A binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of PKA binding pathways.
Contact EDITGENE today to design your custom CRISPR model for protein kinase A binding research.
Frequently Asked Questions About protein kinase A binding
What is protein kinase A binding?
Protein kinase A binding (GO:0051018) is a molecular function describing the physical interaction of a protein with protein kinase A (PKA), a cAMP-dependent kinase.
What genes are involved in protein kinase A binding?
Key genes include PKA subunits (PRKACA, PRKACB, PRKACG, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B) and anchoring proteins such as AKAPs.
How does protein kinase A binding regulate signaling?
Binding localizes PKA to specific subcellular compartments and substrates, ensuring precise phosphorylation events. Isoform-specific sequestration further fine-tunes signaling.
What diseases are associated with protein kinase A binding?
Dysregulation is linked to cancer, Carney complex, metabolic disorders, and infectious diseases like leishmaniasis.
What is the role of AKAPs in protein kinase A binding?
AKAPs are anchoring proteins that bind PKA regulatory subunits and target the kinase to specific cellular locations.
How can I study protein kinase A binding in the lab?
Common methods include pull-down assays, SPR, FRET biosensors, and CRISPR-based genetic screens.
What are the synonyms for GO:0051018?
Synonyms include PKA binding and protein kinase A anchoring activity.
Which PKA subunit isoforms exist?
Catalytic isoforms include PRKACA, PRKACB, and PRKACG; regulatory isoforms include PRKAR1A, PRKAR1B, PRKAR2A, and PRKAR2B.
How does cAMP affect protein kinase A binding?
cAMP binding to regulatory subunits releases active catalytic subunits, enabling them to interact with substrates and anchoring proteins.
Can CRISPR be used to study protein kinase A binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect PKA binding mechanisms.
Conclusion
Protein kinase A binding (GO:0051018) is a fundamental molecular function that governs the specificity and spatial organization of cAMP-dependent signaling. Through interactions with regulatory subunits, anchoring proteins, and substrates, PKA binding controls diverse physiological processes and is implicated in cancer, genetic disorders, and infectious diseases. Understanding these interactions requires a combination of structural, biochemical, and genetic approaches, with CRISPR-based models offering precise tools for functional dissection. Continued research into protein kinase A binding will likely reveal new therapeutic targets and deepen our understanding of signal transduction.
References
- 1. Olivieri C et al.. 2025. Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein.. J Mol Biol 437(23):169466 PMID: 41016548
- 2. Creamer DR et al.. 2024. Isoform-specific sequestration of protein kinase A fine-tunes intracellular signaling during heat stress.. Cell Rep 43(6):114360 PMID: 38865242
- 3. Sowadski JM et al.. 1996. Detergent binding to unmyristylated protein kinase A--structural implications for the role of myristate.. J Bioenerg Biomembr 28(1):7-12 PMID: 8786241
- 4. Adame-Garcia SR et al.. 2026. Protein kinase a regulates cyclooxygenase-2 expression through the RNA-binding proteins HuR and TTP.. J Biol Chem 302(2):111064 PMID: 41421489
- 5. Turnham RE et al.. 2016. Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology.. Gene 577(2):101-8 PMID: 26687711
- 6. Fischer Weinberger R et al.. 2024. A divergent protein kinase A regulatory subunit essential for morphogenesis of the human pathogen Leishmania.. PLoS Pathog 20(3):e1012073 PMID: 38551993
- 7. Alam KA et al.. 2021. Inhibitor binding to mutants of protein kinase A with GGGxxG and GxGxxA glycine-rich loop motifs.. J Mol Recognit 34(4):e2882 PMID: 33191558
- 8. Skroblin P et al.. 2010. Mechanisms of protein kinase A anchoring.. Int Rev Cell Mol Biol 283:235-330 PMID: 20801421
